| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 5 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 5 |
| 2 | TACROLIMUS OINTMENT 0.1% | 5 |
| 3 | CYTARABINE | 3 |
| 4 | MYCOPHENOLATE MOFETIL | 3 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 3 |
| 6 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 2 |
| 7 | CALASPARGASE PEGOL | 2 |
| 8 | METHOTREXATE SODIUM | 2 |
| 9 | PHENYTOIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 2 | 0.0058 |
| 1 | CALASPARGASE PEGOL | 2 | 0.0025 |
| 2 | TRIPTORELIN | 1 | 0.0003 |
| 3 | MITOXANTRONE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 5 | PHENYTOIN | 2 | 0.0001 |
| 6 | BASILIXIMAB | 1 | 0.0001 |
| 7 | CYTARABINE | 3 | 0.0000 |
| 8 | CEPHALEXIN | 1 | 0.0000 |
| 9 | LITHIUM | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 3 | 0.0002 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 3 | Anti-epileptic Agent [EPC] | 2 | 0.0000 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Mood Stabilizer [EPC] | 1 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 8 | Retinoid [EPC] | 1 | 0.0000 |
| 9 | Corticosteroid [EPC] | 4 | 0.0000 |